Sentences with phrase «risk women receiving»

Homebirth increases the risk of perinatal death and brain damage in the lowest risk women receiving care from highly trained midwives (often two) and liberal access to transfer.

Not exact matches

An engaging speaker, Shull has received rave reviews for her talks «How the Psychology of Risk is Fractal» and «Emotions are Also Information» at MIT's Sloan Fellows program, WBR's Equities and Fixed Income Leaders» Summits, LiquidNet, Battle of the Quants, 100 Women in Hedge Funds Behavioral Finance Series and many other conferences.

For example, women receiving treatment for a form of cancer, or any other illness that forces them to ingest some kind of medication, should avoid breastfeeding to lower the risk of potentially harmful chemicals being transferred to the baby.

Executive Director of Commonsense Childbirth Inc, her non profit corporation, she owns and operates The Birth Place birthing center in Winter Garden, Florida and has established an outreach clinic for pregnant women who are at risk of not receiving prenatal care.

The goal of regionalized maternal care is for pregnant women at high risk to receive care in facilities that are prepared to provide the required level of specialized care, thereby reducing maternal morbidity and mortality in the United States.

For women who do not have HIV or other serious infectious diseases, there is little risk to the child who receives her breast milk.

Then they would have the time to really spend with their patients, address concerns, and take their time with «natural - ish cesareans» Reducing the overall number of women in the hospital giving birth (by having a system that supports low risk, healthy moms birthing their babies at home with trained professionals like CPM's and CNM's) would allow moms who birthed through surgery to stay in the hospital longer and receive the one - on - one medical care that they so very much deserve.

Many of the epidural side effects mentioned below are not improved with low - dose or walking epidurals, because women using these techniques may still receive a substantial total dose of local anesthetic, especially when continuous infusions and / or patient - controlled boluses (single large doses) are used.34 The addition of opiate drugs in epidurals or CSEs can create further risks for the mother, such as pruritus (itching) and respiratory depression (see below).

There isn't much information about the risks of injecting women with Meningococcal shots during pregnancy, nor have studies been done on women who receive the doses while nursing a new baby.

A woman choosing place of birth is autonomous if she receives all relevant information on available choices, risks and benefits, is capable of understanding and processing the information and choosing place of birth in the absence of coercion, provided she intends no harm to others and is accountable for the outcome.

The statement emphasizes the need for counseling on the risks and benefits of different feeding options but recognizes that «many women find that receiving information on a range of infant feeding options is not sufficient to enable them to choose and they seek specific guidance.»

The panel recommends that the further use of implants be limited for reconstruction only and that women receiving the implants participate in scientific protocols and that epidemiologic studies be conducted to assess the risk of autoimmune disease.

Women who were randomised to receive midwife - led care were less likely to lose their baby before 24 weeks» gestation, although there were no differences in the risk of losing the baby after 24 weeks, or overall.

Additionally, women who have received hormone therapy may have an increased risk of ovarian cancer.

At two weeks, 38 % (48/128) of women randomised to postnatal intervention were exclusively breast feeding compared with 21 % (28/136) of women who received routine hospital care (relative risk 1.82; 95 % confidence interval 1.14 to 2.90; number needed to treat = 6, 4 to 17).

Conclusions: The outcome of planned home births is at least as good as that of planned hospital births in women at low risk receiving midwifery care in the Netherlands.

Pregnant women should receive regular prenatal care — There is substantial epidemiologic evidence linking a lower risk of SIDS for infants whose mothers obtain regular prenatal care.54, — , 57

It is not only pregnant women receiving antenatal care who are at risk.

The study was conducted prospectively in two periods between 1990 and 1993 among women with low risk pregnancies receiving midwifery care in the province of Gelderland.

Shorter duration of labor was significantly associated with decreased risk of delayed OL but only among women who did not receive pitocin to induce or augment labor.

We know from the volume of calls that we receive to our helpline that women are keen to understand the contribution their lifestyle can make to their own risk of developing breast cancer.

Breast cancer risk rises with age, so women in their 50s and 60s receive more benefit relative to the risk of harm.

Women who used the ring had a 27 percent lower risk of HIV infection than women who received a placebo, scientists reported February 22 in the New England Journal of MediWomen who used the ring had a 27 percent lower risk of HIV infection than women who received a placebo, scientists reported February 22 in the New England Journal of Mediwomen who received a placebo, scientists reported February 22 in the New England Journal of Medicine.

Attanasio, an assistant professor of health policy and management at UMass Amherst's School of Public Health and Health Sciences, explains that a growing body of research at the individual level has shown that compared to women cared for by physicians, women considered at low - risk for complications in childbirth who receive care from midwives have good outcomes that include lower use of interventions such as cesarean delivery.

Dozens of countries add folic acid to flour to ensure that women receive the vitamin, which reduces the risk of babies being born with spina bifida.

After eight years, the risk for developing colon cancer was double for women who received radiation compared to those who had not.

A study of Truvada in sub-Saharan African women at high risk of HIV infection, FEM - PrEP, in April ended early because no difference existed between participants receiving the pills or placebos.

«A prediction tool should be developed in order to estimate which women are at increased risk of breast cancer and should receive breast cancer screening, instead of screening the whole population.

A new narrative review authored by Carl Streed Jr., MD, at Brigham and Women's Hospital, published in the Annals of Internal Medicine, discusses how more research is needed to better understand cardiovascular disease (CVD) and CVD risk factors in transgender patients receiving long term cross-sex hormone therapy.

Although obesity is considered a risk factor for heart disease, the study results suggest that focusing directly or exclusively on weight loss can be counterproductive by discouraging women from keeping health appointments, further reducing the chances that they will receive appropriate monitoring and counseling.

The study, which randomly assigned 1873 HIV - negative pregnant women at three sites in Malawi to receive either strategy, found that the risks of adverse birth outcomes, at 29.9 and 28.8 percent, was similar in the two groups.

Some studies have shown that postmenopausal women receiving HRT had an increased risk of asthma.

The study enrolled 2,831 women with singleton pregnancies at high risk for late preterm delivery (34 0/7 to 36 6/7 weeks) who were randomized to receive antenatal betamethasone intramuscularly or a matching placebo.

Based on a calculation called the «Risk of Ovarian Cancer Algorithm,» women were divided into three groups: those who should receive another CA125 test one year later (low risk), those who should receive a repeat CA125 in three months (intermediate risk), and those who should receive a transvaginal ultrasound and be referred to a gynecologic oncologist (high riRisk of Ovarian Cancer Algorithm,» women were divided into three groups: those who should receive another CA125 test one year later (low risk), those who should receive a repeat CA125 in three months (intermediate risk), and those who should receive a transvaginal ultrasound and be referred to a gynecologic oncologist (high ririsk), those who should receive a repeat CA125 in three months (intermediate risk), and those who should receive a transvaginal ultrasound and be referred to a gynecologic oncologist (high ririsk), and those who should receive a transvaginal ultrasound and be referred to a gynecologic oncologist (high riskrisk).

An average of 5.8 percent of women were found to be of intermediate risk each year, meaning that they should receive a CA125 test in three months.

Studies have found that women treated with radiation therapy for uterine cancer, like men who received radiation therapy for prostate cancer, have an increased risk of developing bladder cancer later in life.

«Sex reassignment surgery may be better for transgender women's health than hormones only: Study investigates metabolic disease risk after receiving only hormone therapy compared to surgery.»

This supports the networked approach that centralises the delivery of specialised neonatal care in high volume units and enables women at risk to be transferred to these units to receive the care they need.»

Physicians receive results only for 12 genes that the evidence suggests can double or quadruple the risk of cancer; that translates to a 25 % to 50 % chance of a woman developing breast cancer, Walsh said.

The researchers say this recent success stems largely from public health initiatives to ensure women in these high - risk populations are tested and receive the proper prenatal care.

Unfortunately, the risks associated with screening mammography increased when the team focused on women with large breasts, who received 2.3 times more radiation than women with smaller breasts.

However, the research showed increased risk for women with large breasts or breast implants, who must often receive extra screening views, increasing their radiation exposure.

Among the high and intermediate risk groups, 570 (91.8 %) pregnant women underwent combined screening in the first trimester while the remaining 51 (8.2 %) women received other forms of prenatal screening, including the integrated test and second trimester maternal serum screening.

SEATTLE, Feb. 05, 2018 (GLOBE NEWSWIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the publication of a landmark study in which Danish researchers used the Prosigna ® Breast Cancer Assay risk of recurrence (ROR) score to accurately predict rates of 10 - year distant recurrence (DR) of cancer in a comprehensive and population - based cohort including all postmenopausal women in Denmark with early - stage hormone receptor (HR)- positive, Her - 2 negative breast cancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 and 2003.

About 8 in 10 women at highest risk for BRCA mutations — because of family history or ancestry — said they had wanted testing, but only a little more than half received it.

According to ACS guidelines, women with a lifetime risk of 20 percent or greater should receive annual MRI breast screenings in additional to mammograms, and women at 15 to 20 percent lifetime risk should talk with their doctors about the benefits and limitations of adding MRI screening to their yearly mammogram.

In this issue of ONCOLOGY, Overholser and colleagues review a woman's risk of developing breast cancer after receiving RT to the chest, and identify strategies to reduce this risk.

They also randomly assigned 49 pregnant women at risk for preterm labor to receive either the braided Mersilene or single - filament Ethilon stitch.

Women who receive chemotherapy and radiation for breast cancer could be at greater risk for heart disease, even years after treatment, the American Heart Association warned in February 2018.

The researchers said the third group of women — those treated with TDF along with emtricitabine and atazanavir / ritonavir — actually had a 10 percent lower risk of premature birth and other complications than those who didn't receive TDF.